Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Plasmapheresis for Nephrogenic Fibrosing Dermopathy (NFD)/Nephrogenic Systemic Fibrosis (NSF) and Understanding Its Etiology

NCT01078987 is registered in ClinicalTrials.gov with Loma Linda University as lead sponsor.

NCT NCT01078987
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01078987 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Plasmapheresis for Nephrogenic Fibrosing Dermopathy (NFD)/Nephrogenic Systemic Fibrosis (NSF) and Understanding Its Etiology
Lead sponsor
Loma Linda University
Phase
Phase 4
Overall status
Terminated
Start date
February 28, 2002
Completion date
March 31, 2012
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nephrogenic fibrosing dermopathy, nephrogenic systemic fibrosis